XML 76 R56.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurements - Reconciliation of Level 3 Assets and Liabilities (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 26, 2020
Sep. 28, 2019
Mar. 30, 2019
Sep. 26, 2020
Sep. 28, 2019
Measured on a recurring basis | Level 3          
Contingent Consideration          
Beginning balance $ 12.1 $ 12.1 $ 15.3 $ 11.9 $ 15.3
Changes in value 0.7 1.1   0.9 (0.9)
Settlements and other adjustments 0.0 0.0   0.0 (1.2)
Ending balance 12.8 13.2   12.8 13.2
Royalty Pharma Contingent Milestone Payments          
Royalty Pharma Contingent Milestone Payments          
Payments received     (250.0)    
Royalty Pharma Contingent Milestone Payments | Measured on a recurring basis | Level 3          
Royalty Pharma Contingent Milestone Payments          
Beginning balance 99.0 89.1 $ 323.2 95.3 323.2
Payments received 0.0 0.0   0.0 (250.0)
Change in fair value 22.2 2.6   25.9 18.5
Ending balance $ 121.2 $ 91.7   $ 121.2 $ 91.7